Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon for Insomnia in Patients with Major Depressive Disorder
NCT02669082Phase 4Completed
- Sponsor
- Takeda
- Start
- May 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramelteon in Insomnia, sponsored by Takeda. Started May 2017; status: completed.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT02669082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02669082.